For future access to innovative technologies/
novel therapeutic drug targets and collaboration
with early stage startup companies

NewsList

List

Mission

Ono Venture Investment, Inc. (OVI) is the corporate venture capital arm of Ono Pharma,
an R&D-oriented pharmaceutical company succeeded in delivery of “First in class”
medicines to patients such as OPDIVO® (nivolumab).

Learn More

Priority Areas

  • Oncology

  • Immunology & Inflammation

  • Neurology

To fulfill our mission as a Corporate Venture Capital, OVI prioritizes to make investment in novel startups possessing products and
platforms potentially with high synergy to R&D of our parent company, Ono Pharma.

Learn More
Ono Pharma

Ono Pharma, headquartered in Osaka, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas.

ONO PHARMA website

Ono has another CVC, Ono Digital health Investment,GK("Ono Digital health").
Ono Digital health invests in start-up/venture companies engaged in healthcare-related business.
They view healthcare as a condition in which the degree of satisfaction with life is high physically and socially, therefore they invest in areas that are not restricted to Ono Pharma's R&D domain.

ONO DIGITAL HEALTH INVESTMENT,GK website